Home > > > Report Detail

US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 08-Jan-2019
No. of pages: 125
Inquire Before Buying

Acne and Rosacea are the most common dermatological disorders affecting people in the United States. Acne is a chronic skin disorder in which the hair follicles become blocked and/or inflamed, which is most prevalent among teenagers. However, some people may suffer from acne well into their 30s and 40s even. Acne can occur in forms ranging from comedones to cystic lesions, depending upon severity.

Rosacea is a common skin condition that causes redness and visible blood vessels on the nose, cheeks, and forehead. Rosacea can occur to anyone. But it is most commonly affects adults over age 30, particularly women with fair skin. The condition of rosacea is increasingly widespread in the U.S. and affecting approximately 16 million population in the country.

Topical drugs currently dominate both markets in the U.S. Systemic medications such as oral antibiotics, hormonal agents or other drugs are also used for the treatment of acne and rosacea. The ongoing development of new drugs is expected to witness an extraordinary growth rate due to higher efficacy, convenient dosing and fewer side effects.

The increase in emotional burden due to these skin conditions is a key factor driving the growth of the market. Growing awareness regarding rosacea and acne treatment options has significantly driven the market in the U.S. Rising purchasing power and mounting healthcare expenditure has also fuelled the growth of the market in the region. Despite being common skin disorders, advancement in treatment has been limited over the past years exhibiting a great opportunity of growth in the future. The companies are developing new treatment options, in which, most products are in late-stage indicating an optimistic future for the market.

The report “U.S. Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. market. The report profiles the key players of the market including Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel Technologies.

US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. Market Overview
1.1 Acne
1.1.1 Acne Overview
1.1.2 Causes & Symptoms of Acne
1.1.3 Classification of Severity
1.1.4 Treatment for Acne
1.1.5 Acne Treatment Continuum
1.1.6 Limitations of Acne Treatments
1.2 Rosacea
1.2.1 Rosacea Overview
1.2.2 Symptoms and Causes of Rosacea
1.2.3 Treatment for Rosacea

2. The U.S. Acne Market
2.1 The U.S. Acne Market Forecast by Value
2.2 The U.S. Acne Market by Drug Type
2.3 The U.S. Acne Topical Drugs by Brand
2.4 The U.S. Acne Oral Antibiotics by Brand
2.5 The U.S. Acne Market Forecast by Product
2.5.1 The U.S. Minocycline Revenue Forecast
2.5.2 The U.S. Retin-A Generics Revenue Forecast
2.5.3 The U.S. Epiduo/Epiduo Forte Revenue Forecast
2.5.4 The U.S. Aczone Revenue Forecast
2.5.5 The U.S. Onexton Revenue Forecast
2.5.6 The U.S. Solodyne Revenue Forecast
2.5.7 The U.S. Oracea Revenue Forecast
2.5.8 The U.S. Ziana Revenue Forecast
2.6 The U.S. Acne Prevalence Forecast
2.7 The U.S. Acne Addressable Population
2.7.1 The U.S. Acne Addressable Population Forecast
2.7.2 The U.S. Acne Addressable Population by Severity
2.7.3 The U.S. Acne Mild Population Forecast
2.7.4 The U.S. Acne Moderate Population Forecast
2.7.5 The U.S. Acne Severe Population Forecast
2.8 The U.S. Acne Topical Treatment Population
2.8.1 The U.S. Acne Topical Treatment Population Forecast
2.8.2 The U.S. Acne Topical Treatment Population by Severity
2.8.3 The U.S. Acne Topical Treatment Mild Population Forecast
2.8.4 The U.S. Acne Topical Treatment Moderate Population Forecast
2.8.5 The U.S. Acne Severe Topical Treatment Population Forecast
2.9 FMX101
2.9.1 The U.S. FMX-101 Drug Patient Population Forecast
2.9.2 The U.S. FMX-101 Drug Market Share Forecast
2.9.3 The U.S. FMX-101 Drug Cost Forecast
2.9.4 The U.S. FMX-101 Drug Revenue Forecast
2.10 TWIN
2.10.1 The U.S. TWIN Drug Patient Population Forecast
2.10.2 The U.S. TWIN Drug Market Share Forecast
2.10.3 The U.S. TWIN Drug Cost Forecast
2.10.4 The U.S. TWIN Drug Revenue Forecast
2.11 SIRS-T
2.11.1 The U.S. SIRS-T Drug Patient Population Forecast
2.11.2 The U.S. SIRS-T Drug Market Share Forecast
2.11.3 The U.S. SIRS-T Drug Cost Forecast
2.11.4 The U.S. SIRS-T Drug Revenue Forecast

3. The U.S. Rosacea Market
3.1 The U.S. Rosacea Market Forecast by Value
3.2 The U.S. Rosacea Total Cases Forecast
3.3 The U.S. Rosacea Market by Drug Type
3.4 The U.S. Rosacea Market by Drug Type
3.4.1 The U.S. Rosacea Market Revenue and Prescription by Drug Type
3.4.2 The U.S. Rosacea Market Revenue and Prescription by Brand
3.5 The U.S. Rosacea Prevalence Forecast
3.6 The U.S. Rosacea Addressable Population
3.6.1 The U.S. Rosacea Addressable Population Forecast
3.6.2 The U.S. Rosacea Addressable Population by Severity
3.6.3 The U.S. Rosacea Mild Population Forecast
3.6.4 The U.S. Rosacea Moderate Population Forecast
3.6.5 The U.S. Rosacea Severe Population Forecast
3.7 The U.S. Rosacea Topical Treatment Population
3.7.1 The U.S. Rosacea Topical Treatment Population Forecast
3.7.2 The U.S. Rosacea Topical Treatment Population by Severity
3.7.3 The U.S. Rosacea Topical Treatment Mild Population Forecast
3.7.4 The U.S. Rosacea Topical Treatment Moderate Population Forecast
3.7.5 The U.S. Rosacea Severe Topical Treatment Population Forecast
3.8 FMX103
3.8.1 The U.S. FMX-103 Drug Patient Population Forecast
3.8.2 The U.S. FMX-103 Drug Market Share Forecast
3.8.3 The U.S. FMX-103 Drug Revenue Forecast
3.9 VERED
3.9.1 The U.S. VERED Drug Patient Population Forecast
3.9.2 The U.S. VERED Drug Market Share Forecast
3.9.3 The U.S. VERED Drug Cost Forecast
3.9.4 The U.S. VERED Drug Revenue Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Youth Population
4.1.2 Rising Purchasing Power
4.1.3 Escalating Healthcare Expenditure
4.1.4 Vast Market Opportunity
4.1.5 Sedentary Lifestyle and Unhealthy Eating Habits
4.2 Key Trends & Developments
4.2.1 Growing Awareness
4.2.2 Rising Medical Tourism
4.2.3 Preference for Minimally Invasive Procedures
4.2.4 Personal Appearance Importance
4.3 Challenges
4.3.1 Entry of Generic Drugs
4.3.2 Side Effects of Acne and Rosacea Therapies
4.3.3 Tough Regulations

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Global Acne Market- Drug Comparison by Company
5.1.3 Global Late Stage Acne Market- Drug Comparison by Company
5.1.4 Global Mid Stage Acne Market- Drug Comparison by Company
5.1.2 Global Rosacea Market- Drug Comparison by Company

6. Company Profiles
6.1 Bausch Health Companies, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Foamix Pharmaceuticals Ltd.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Allergan Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Sol Gel Technologies Ltd.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

Acne Treatment Continuum
Limitations of Commonly Used Acne Treatments
The U.S. Rosacea Market Revenue and Prescription by Drug Type (2017)
The U.S. Rosacea Drug Revenue and Prescription by Brand (2017)
Key Players - Revenue & Market Cap Comparison (2017)
Global Acne Market- Drug Comparison by Company (2017)
Global Late Stage Acne Market- Drug Comparison by Company (2017)
Global Mid Stage Acne Market- Drug Comparison by Company (2017)
Global Rosacea Market- Drug Comparison by Company (2017)
Foamix Pharmaceuticals Product Pipeline (2017)
Sol Gel Technologies Ltd. Product Pipeline (2017)

List of Figures

Types of Acne
Treatment for Acne
Types of Rosacea
Treatment for Rosacea
The U.S. Acne Market Forecast by Value (2017-2022)
The U.S. Acne Market by Drug Type (2017)
The U.S. Acne Topical Drugs by Brand (2017)
The U.S. Acne Oral Antibiotics by Brand (2017)
The U.S. Minocycline Revenue Forecast (2017-2022)
The U.S. Retin-A Generics Revenue Forecast (2017-2022)
The U.S. Epiduo/Epiduo Forte Revenue Forecast (2017-2022)
The U.S. Aczone Revenue Forecast (2017-2022)
The U.S. Onexton Revenue Forecast (2017-2022)
The U.S. Solodyne Revenue Forecast (2017-2022)
The U.S. Oracea Revenue Forecast (2017-2022)
The U.S. Ziana Revenue Forecast (2017-2022)
The U.S. Acne Prevalence Forecast (2017-2022)
The U.S. Acne Addressable Population Forecast (2017-2022)
The U.S. Acne Addressable Population by Severity (2017)
The U.S. Acne Mild Population Forecast (2017-2022)
The U.S. Acne Moderate Population Forecast (2017-2022)
The U.S. Acne Severe Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Population by Severity (2017)
The U.S. Acne Topical Treatment Mild Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Moderate Population Forecast (2017-2022)
The U.S. Acne Severe Topical Treatment Population Forecast (2017-2022)
The U.S. FMX-101 Drug Patient Population Forecast (2020-2024)
The U.S. FMX-101 Drug Market Share Forecast (2020-2024)
The U.S. FMX-101 Drug Cost Forecast (2020-2024)
The U.S. FMX-101 Drug Revenue Forecast (2020-2024)
The U.S. TWIN Drug Patient Population Forecast (2021-2025)
The U.S. TWIN Drug Market Share Forecast (2021-2025)
The U.S. TWIN Drug Cost Forecast (2021-2025)
The U.S. TWIN Drug Revenue Forecast (2021-2025)
The U.S. SIRS-T Drug Patient Population Forecast (2022-2026)
The U.S. SIRS-T Drug Market Share Forecast (2022-2026)
The U.S. SIRS-T Drug Cost Forecast (2022-2026)
The U.S. SIRS-T Drug Revenue Forecast (2022-2026)
The U.S. Rosacea Market Forecast by Value (2017-2022)
The U.S. Rosacea Total Cases Forecast (2017-2022)
The U.S. Rosacea Market by Drug Type (2017)
The U.S. Rosacea Drug Revenue Share by Brand (2017)
The U.S. Rosacea Prevalence Forecast (2017-2022)
The U.S. Rosacea Addressable Population Forecast (2017-2022)
The U.S. Rosacea Addressable Population by Severity (2017)
The U.S. Rosacea Mild Population Forecast (2017-2022)
The U.S. Rosacea Moderate Population Forecast (2017-2022)
The U.S. Rosacea Severe Population Forecast (2017-2022)
The U.S. Rosacea Topical Treatment Population Forecast (2017-2022)
The U.S. Rosacea Topical Treatment Population by Severity (2017)
The U.S. Rosacea Topical Treatment Mild Population Forecast (2017-2022)
The U.S. Rosacea Topical Treatment Moderate Population Forecast (2017-2022)
The U.S. Rosacea Severe Topical Treatment Population Forecast (2017-2022)
The U.S. FMX-103 Drug Patient Population Forecast (2021-2025)
The U.S. FMX-103 Drug Market Share Forecast (2021-2025)
The U.S. FMX-103 Drug Revenue Forecast (2021-2025)
The U.S. VERED Drug Patient Population Forecast (2021-2025)
The U.S. VERED Drug Market Share Forecast (2021-2025)
The U.S. VERED Drug Cost Forecast (2021-2025)
The U.S. VERED Drug Revenue Forecast (2021-2025)
The U.S. Acne Patients by Age (2017)
The U.S. GNI Per Capita (2013-2017)
The U.S. Healthcare Expenditure Per Capita (2013-2017)
The U.S. Dermatology Drugs Market (2013-2017)
Bausch Health Companies Revenue by Segments (2017)
Bausch Health Companies Revenue and Net Loss (2013-2017)
Bausch Health Companies Research & Development Expenses (2015-2017)
Foamix Pharmaceuticals Revenue and Net Income (2013-2017)
Foamix Pharmaceuticals R&D Expenses (2015-2017)
Allergan Net Revenue by Business Segments (2017)
Allergan Net Revenue and Net Income (Loss) (2013-2017)
Allergan Research and Development Expenditures (2015-2017)
Sol Gel Technologies Ltd. Revenue and Net Loss (2013-2017)
Sol Gel Technologies Ltd. Research & Development Expenses (2015-2017)

  • Global Surgical Overalls Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
  • Global Medical or Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
  • Global Hospital Gas Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Nurse Call Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period. The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
  • Global Pediatric Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
  • Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Telepharmacy market: According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
  • Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Vinca Alkaloid Compounds market: According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
  • Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Bladder Cancer market: According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years. Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market: According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs